Skip to main content
Clinical Trials/ACTRN12624000527561
ACTRN12624000527561
Recruiting
Phase 4

Postoperative analgesic efficacy of intrathecal Nalbuphine with Bupivacaine inspinal anesthesia for anorectal surgery : A randomized controlled trial

antapat Soonthonnitikul0 sites90 target enrollmentApril 28, 2024

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
antapat Soonthonnitikul
Enrollment
90
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 28, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
antapat Soonthonnitikul

Eligibility Criteria

Inclusion Criteria

  • 1\. patients under going elective anorectal surgery under spinal anesthesia at King Chulalongkorn Memorial Hospital age from 18 to 65 year old
  • 2\. American Society of Anesthesiologists Physical Status I to II
  • 3\. patients consented to participate in our research

Exclusion Criteria

  • 1\. patients that have history of allergy to research drugs
  • 2\. patients that can't report their pain score
  • 3\. patients with history of chronic pain (more than 3 months) and have history of morphine use
  • 4\. patients with skin disease or preopearive pruritic symptoms
  • 5\. patients that require postoperative intentive care unit
  • 6\. patients contraindicated to spinal anesthesia

Outcomes

Primary Outcomes

Not specified

Similar Trials